Global AI In Cancer Diagnostics Market Report 2024

AI In Cancer Diagnostics Global Market Report 2024 – By Component (Software Solutions, Hardware, Services), By Cancer Type ( Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types), By Application (Screening And Diagnosis, Tumor Identification, Monitoring), By End User (Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2024-2033

AI In Cancer Diagnostics Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
AI In Cancer Diagnostics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

AI In Cancer Diagnostics Market Definition

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency.

The main types of components of AI in cancer diagnostics are software solutions, hardware, and services. Software solutions refer to the use of artificial intelligence (AI) and machine learning (ML) technologies to improve the accuracy and efficiency of cancer detection, prognosis, and treatment selection. The various types of cancer include breast cancer, lung cancer, brain tumor, skin cancer and cervical cancer, prostate and colorectal cancer, and others. These are used in various applications such as screening and diagnosis, tumor identification, and monitoring and also by various end users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

AI In Cancer Diagnostics Market Segmentation

The ai in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

Global AI In Cancer Diagnostics Market Size 2023 to 2028: Graph

AI In Cancer Diagnostics Market Size 2024 And Growth Rate

The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.55 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of ai applications beyond imaging.

AI In Cancer Diagnostics Market Growth Forecast

The ai in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to emergence of explainable ai, global increase in healthcare it spending, integration with electronic health records (ehr), personalized medicine adoption, continued advances in ai algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.

AI In Cancer Diagnostics Market Driver: Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics

The increasing prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The integration of AI in cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For instance, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with many deaths. Therefore, the increasing prevalence of cancer is driving the growth of artificial intelligence in the cancer diagnostics market.

Global AI In Cancer Diagnostics Market Major Players

Major companies operating in the ai in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

Global AI In Cancer Diagnostics Market Trend: AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe

Major companies operating in the AI in cancer diagnostics market are experiencing significant growth due to advancements in AI-powered digital pathology solutions for cancer diagnosis. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence (AI) algorithms to detect cancer and other diagnostic features in multiple tissue types, providing accurate and timely cancer diagnosis, support case prioritization, and reproducible diagnoses. For instance, In November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to improve accuracy, provide AI-powered decision support tools, streamline reporting, enhance laboratory efficiency, and increase diagnostic confidence.

AI In Cancer Diagnostics Market Merger And Acquisition: Lunit Acquires Volpara Transforming AI Cancer Diagnostics

In December 2023, Lunit, a South Korean-based AI company, acquired Volpara for $193 million. This acquisition is expected to position the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market, due to Volpara's strong presence in over 2,000 medical sites across the U.S. and its extensive database of over 100 million high-quality mammogram images. The acquisition is contingent upon Volpara shareholders' and New Zealand High Court's approval. Volpara is a New Zealand-based company that provides AI-powered software for personalized screening and early detection of breast cancer.

Regional Insights For The Global AI In Cancer Diagnostics Market

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI In Cancer Diagnostics Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $0.66 billion
Revenue Forecast In 2033 $1.38 billion
Growth Rate CAGR of 20.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types
3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring
4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus; Guardant Health; Lunit Inc.; Paige AI Inc.; Ada Health GmbH; Viz.ai Inc.; Butterfly Network Inc.; Insilico Medicine; BenevolentAI SA SA; Enlitic Inc.; Ibex Medical Analytics; Kheiron Medical Technologies Limited; CureMetrix Inc.; CancerIQ Inc.; MultiplAI Health; Freenome Holdings Inc.; SkinVision; Entopsis; Owkin; Imagen Technologies; Panakeia Technologies; EchoPixel Inc.; X-Zell Inc.; Cyrcadia Health; Oncora Medical; Xilis
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. AI In Cancer Diagnostics Market Characteristics

    3. AI In Cancer Diagnostics Market Trends And Strategies

    4. AI In Cancer Diagnostics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global AI In Cancer Diagnostics Market Size and Growth

    5.1. Global AI In Cancer Diagnostics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. AI In Cancer Diagnostics Market Segmentation

    6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Software Solutions

    Hardware

    Services

    6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Lung Cancer

    Brain Tumor

    Skin Cancer And Cervical Cancer

    Prostate And Colorectal Cancer

    Other Cancer Types

    6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Screening And Diagnosis

    Tumor Identification

    Monitoring

    6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Diagnostic Centers

    Medical Research Institutes

    Contract Research Organizations

    7. AI In Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific AI In Cancer Diagnostics Market

    8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China AI In Cancer Diagnostics Market

    9.1. China AI In Cancer Diagnostics Market Overview

    9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India AI In Cancer Diagnostics Market

    10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan AI In Cancer Diagnostics Market

    11.1. Japan AI In Cancer Diagnostics Market Overview

    11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia AI In Cancer Diagnostics Market

    12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia AI In Cancer Diagnostics Market

    13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea AI In Cancer Diagnostics Market

    14.1. South Korea AI In Cancer Diagnostics Market Overview

    14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe AI In Cancer Diagnostics Market

    15.1. Western Europe AI In Cancer Diagnostics Market Overview

    15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK AI In Cancer Diagnostics Market

    16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany AI In Cancer Diagnostics Market

    17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France AI In Cancer Diagnostics Market

    18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy AI In Cancer Diagnostics Market

    19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain AI In Cancer Diagnostics Market

    20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe AI In Cancer Diagnostics Market

    21.1. Eastern Europe AI In Cancer Diagnostics Market Overview

    21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia AI In Cancer Diagnostics Market

    22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America AI In Cancer Diagnostics Market

    23.1. North America AI In Cancer Diagnostics Market Overview

    23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA AI In Cancer Diagnostics Market

    24.1. USA AI In Cancer Diagnostics Market Overview

    24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada AI In Cancer Diagnostics Market

    25.1. Canada AI In Cancer Diagnostics Market Overview

    25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America AI In Cancer Diagnostics Market

    26.1. South America AI In Cancer Diagnostics Market Overview

    26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil AI In Cancer Diagnostics Market

    27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East AI In Cancer Diagnostics Market

    28.1. Middle East AI In Cancer Diagnostics Market Overview

    28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa AI In Cancer Diagnostics Market

    29.1. Africa AI In Cancer Diagnostics Market Overview

    29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

    30.1. AI In Cancer Diagnostics Market Competitive Landscape

    30.2. AI In Cancer Diagnostics Market Company Profiles

    30.2.1. Microsoft Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. IBM Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Babylon Healthcare Services Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Verily Life Sciences LLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Tempus

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

    31.1. Guardant Health

    31.2. Lunit Inc.

    31.3. Paige AI Inc.

    31.4. Ada Health GmbH

    31.5. Viz.ai Inc.

    31.6. Butterfly Network Inc.

    31.7. Insilico Medicine

    31.8. BenevolentAI SA

    31.9. Enlitic Inc.

    31.10. Ibex Medical Analytics

    31.11. Kheiron Medical Technologies Limited

    31.12. CureMetrix Inc.

    31.13. CancerIQ Inc.

    31.14. MultiplAI Health

    31.15. Freenome Holdings Inc.

    32. Global AI In Cancer Diagnostics Market Competitive Benchmarking

    33. Global AI In Cancer Diagnostics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

    35. AI In Cancer Diagnostics Market Future Outlook and Potential Analysis

    35.1 AI In Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities

    35.2 AI In Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities

    35.3 AI In Cancer Diagnostics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Microsoft Corporation  Financial Performance
  • Table 76: IBM Corporation Financial Performance
  • Table 77: Babylon Healthcare Services Ltd. Financial Performance
  • Table 78: Verily Life Sciences LLC Financial Performance
  • Table 79: Tempus Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Microsoft Corporation  Financial Performance
  • Figure 76: IBM Corporation Financial Performance
  • Figure 77: Babylon Healthcare Services Ltd. Financial Performance
  • Figure 78: Verily Life Sciences LLC Financial Performance
  • Figure 79: Tempus Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the AI in cancer diagnostics market?

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency. For further insights on the AI in cancer diagnostics market, request a sample here

How will the AI in cancer diagnostics market drivers and restraints affect the AI in cancer diagnostics market dynamics? What forces will shape the AI in cancer diagnostics industry going forward?

The AI in cancer diagnostics market major growth driver - rising cancer cases propel advances artificial intelligence takes center stage in cancer diagnostics. For further insights on the AI in cancer diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the AI in cancer diagnostics market ?

The AI in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.55 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of ai applications beyond imaging. The AI in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to emergence of explainable ai, global increase in healthcare it spending, integration with electronic health records (ehr), personalized medicine adoption, continued advances in ai algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology. For further insights on the AI in cancer diagnostics market, request a sample here

How is the AI in cancer diagnostics market segmented?

The AI in cancer diagnostics market is segmented
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types
3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring
4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research OrganizationsFor further insights on the AI in cancer diagnostics market,
request a sample here

Which region has the largest share of the AI in cancer diagnostics market? What are the other regions covered in the report?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the AI in cancer diagnostics market, request a sample here.

Who are the major players in the AI in cancer diagnostics market?

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation , IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis For further insights on the AI in cancer diagnostics market, request a sample here.

What are the key trends in the AI in cancer diagnostics market?

Major trend in the AI in cancer diagnostics market - ai-driven pathology solutions transform cancer diagnosis in europe. For further insights on the AI in cancer diagnostics market, request a sample here.

What are the major opportunities in the AI in cancer diagnostics market? What are the strategies for the AI in cancer diagnostics market?

For detailed insights on the major opportunities and strategies in the AI in cancer diagnostics market, request a sample here.

How does the AI in cancer diagnostics market relate to the overall economy and other similar markets?

For detailed insights on AI in cancer diagnostics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the AI in cancer diagnostics industry?

For detailed insights on the mergers and acquisitions in the AI in cancer diagnostics industry, request a sample here.

What are the key dynamics influencing the AI in cancer diagnostics market growth? SWOT analysis of the AI in cancer diagnostics market.

For detailed insights on the key dynamics influencing the AI in cancer diagnostics market growth and SWOT analysis of the AI in cancer diagnostics industry, request a sample here.